Qiagen NV | QIA - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
argenx SE USD 1.02B 118M 2026-06
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 47M 22.83M 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Moderna USD 1.78B 242M 2026-03
Organon & Co USD 903M 387M 2026-03
Qiagen NV USD 375.69M 42.85M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Viatris USD 3.54B 323.9M 2026-03
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03